Apimeds Pharmaceuticals US, Inc. APUS
2.70 USD -0.22 (-7.53%)
Nov 5, 2026, 2:24 PM EST
2.65 Day range 2.88
1.51 52-week range 59.70
- YTD
- -83.54%
- 1 year
- -90.15%
Financial health
Altman Z-Score
-2.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5